Press Releases Keyword Search Year None2020201920182017201620152014 Auris Medical Provides Update on Intranasal Betahistine Development Program 04/03/20 Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine 03/05/20 Auris Medical Highlights Publication of Study Results Demonstrating Betahistine’s Antiepileptogenic and Anticonvulsant Activity in Murine Model 02/25/20 Auris Medical Announces Notice of Allowance for European Patent Application 01/10/20
Auris Medical Highlights Publication of Study Results Demonstrating Betahistine’s Antiepileptogenic and Anticonvulsant Activity in Murine Model 02/25/20
